Wilson Sonsini Goodrich & Rosati advised Warburg Pincus on the deal. Abbisko Therapeutics Co., Ltd., an oncology-focused biopharmaceutical company, announced the completion of its Series D…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
